World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
77003
World Ranking
6636
National Ranking
3516

Overview

Antonio C. Wolff is affiliated with Johns Hopkins University in the United States and has contributed extensively to research in medicine, particularly within the fields of oncology and cancer biology. Their work spans multiple subfields including oncology, cancer research, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and genetics.

The research topics addressed by Wolff center primarily on breast cancer treatment studies, HER2/EGFR in cancer research, advanced breast cancer therapies, cancer treatment and pharmacology, cancer genomics and diagnostics, cancer survivorship and care, and monoclonal and polyclonal antibodies research.

Wolff has published frequently in several notable scientific venues, reflecting the focus of their research domains. The top publication outlets include:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • Annals of Oncology
  • Clinical Cancer Research

Significant recent papers authored or coauthored by Wolff illustrate both clinical and molecular aspects of breast cancer diagnostics and therapeutics. Key publications include:

  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update" (2020, Journal of Clinical Oncology)
  • "TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes" (2020, Journal of Clinical Oncology)
  • "Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update" (2023, Journal of Clinical Oncology)
  • "Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update" (2020, Archives of Pathology & Laboratory Medicine)
  • "Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study" (2021, The Lancet Oncology)

The scientist has collaborated frequently with other researchers in the oncology field. The most frequent coauthors include:

  • Ian E. Krop
  • Eric P. Winer
  • Vered Stearns
  • Lisa A. Carey
  • Mothaffar F. Rimawi

Best Publications

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    M. Elizabeth H. Hammond;Daniel F Hayes;Mitch Dowsett;D Craig Allred

  • American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

    Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Antonio C Wolff;M Elizabeth Hale Hammond;Kimberly H Allison;Brittany E Harvey

  • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

    Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty

  • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

    Antonio C. Wolff;M. Elizabeth H Hammond;David G. Hicks;Mitch Dowsett

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

    Antonio C. Wolff;M. Elizabeth Hale Hammond;Kimberly H. Allison;Brittany E. Harvey

  • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Gary H. Lyman;Armando E. Giuliano;Mark R. Somerfield;Al B. Benson

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Thomas J. Smith;James Khatcheressian;Gary H. Lyman;Howard Ozer

  • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    Eric P. Winer;Clifford Hudis;Harold J. Burstein;Antonio C. Wolff

  • Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    Sylvia Adams;Robert J. Gray;Sandra Demaria;Lori Goldstein

  • Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    Joseph A. Sparano;Joseph A. Sparano;Molin Wang;Silvana Martino;Vicky Jones

  • Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

    Bethany B. Barone;Hsin Chieh Yeh;Claire F. Snyder;Kimberly S. Peairs

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

    Sara M. Tolaney;William T. Barry;Chau T. Dang;Denise A. Yardley

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    M. Elizabeth H. Hammond;Daniel F. Hayes;Antonio C. Wolff;Pamela B. Mangu

  • Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

    James L. Khatcheressian;Patricia Hurley;Elissa Bantug;Laura J. Esserman

  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    Paul E. Goss;James N. Ingle;Kathleen I. Pritchard;Nicholas J. Robert

  • American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting

    James L. Khatcheressian;Antonio C. Wolff;Thomas J. Smith;Eva Grunfeld

  • Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

    Harold J. Burstein;Anthony D. Elias;Hope S. Rugo;Melody A. Cobleigh

  • Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

    Hyman B. Muss;Hyman B. Muss;Donald A. Berry;Constance T. Cirrincione;Maria Theodoulou

Frequent Co-Authors

Vered Stearns
Vered Stearns Johns Hopkins University
Steven N. Goodman
Steven N. Goodman Stanford University
Giovanni Parmigiani
Giovanni Parmigiani Harvard University
Eric B. Bass
Eric B. Bass Johns Hopkins University
Eric P. Winer
Eric P. Winer Yale University
Ian E. Krop
Ian E. Krop Harvard University
Nancy E. Davidson
Nancy E. Davidson University of Washington
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
Harold J. Burstein
Harold J. Burstein Harvard University
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers a variety of online degree options for those seeking flexibility and affordability while advancing their careers. Many students consider online nurse practitioner programs to gain advanced clinical skills and more responsibility as healthcare providers.

For those just starting out, exploring affordable nursing programs online is a practical way to enter the healthcare industry without incurring massive debt. These programs often provide pathways to earning a Registered Nurse (RN) license.

Nurses aiming to elevate their educational qualifications may pursue a terminal degree through phd nursing programs, focusing on research, leadership, or education roles. Meanwhile, working RNs can seamlessly advance their credentials via cheapest rn to bsn online programs that are designed for convenience and cost-effectiveness.

Each of these online pathways can help pave the way for further specialization, career progression, and increased salary potential in the U.S. healthcare sector.

Best Scientists Citing Antonio C. Wolff

Trending Scientists

Recently Published Articles